Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

14.03.17	Pfizer Launches Zavicefta In The U.K. & Germany - Quick Facts (RTTNews)
10.03.17	Investors: Stock Option Reports for Covered Call reports for Facebook, General Electric, Marathon Oil Corporation, Pfizer Inc. and Tailored Brands Inc. (PR Newswire)
07.03.17	Drug Makers Stocks Under Scanner -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
28.02.17	Merck, Pfizer: FDA Accepts For Priority Review BLA For Avelumab - Quick Facts (RTTNews)
28.02.17	FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review (PR Newswire)
28.02.17	FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review (PR Newswire)
22.02.17	Investors: Option reports for Advanced Micro Devices, Macy's Incorporated, Nike, Pfizer Inc. and Vipshop Holdings (PR Newswire)
21.02.17	Pfizer Says FDA Accepts BLA For Inotuzumab Ozogamicin - Quick Facts (RTTNews)
16.02.17	Pfizer Reports Results From Oral Strategy Trial Of XELJANZ Compared To Humira (RTTNews)
07.02.17	Covered Call Reports for Cabot Oil and Gas Corp., Hasbro, Newell Brands Incorporated, Pfizer Inc., and Williams Companies from InvestorsObserver. (PR Newswire)
03.02.17	Pfizer Enters $5 Bln Accelerated Share Repurchase Agreement With Citibank (RTTNews)
31.01.17	Pfizer Inc. Q4 Profit Retreats 13% (RTTNews)
27.01.17	Pfizer Gets Positive CHMP Opinion In Europe For XELJANZ (RTTNews)
27.01.17	IMGN Marches Forward, FDA Nod For ZLTQ, Knight Lends Shine To PLX (RTTNews)
26.01.17	Pfizer Announces Results From Phase 2 Study Of C. Difficile Vaccine (RTTNews)
19.01.17	Milner Therapeutics Institute Announces New Partnership with US Pharmaceutical Company Pfizer (PR Newswire)
19.01.17	Milner Therapeutics Institute Announces New Partnership with US Pharmaceutical Company Pfizer (PR Newswire)
18.01.17	Investors: Free Options Reports for Apple, Mattel Inc, Morgan Stanley, Pfizer Inc. and Reynolds American Incorporated (PR Newswire)
18.01.17	Technical Reports on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
09.01.17	Abbott Laboratories, The Gap, Micron, Pfizer Inc., and Wells Fargo & Co. and more offer option-trading opportunities that offer returns of more than 19% (PR Newswire)
05.01.17	Pfizer's Potential Biosimilar To Humira Reveals Positive Data - Quick Facts (RTTNews)
05.01.17	Molecular Stethoscope Completes $8.2M Seed Financing to Advance Circulating Cell-Free RNA Liquid Biopsy Platform; Announces Research Collaboration with Pfizer (PR Newswire)
04.01.17	Investors: Stock reports for Bank of America, Chesapeake Energy, Ford, Pfizer Inc. and US Oil Fund include trade ideas with returns over 21% (PR Newswire)
04.01.17	Spark Therapeutics Announces Milestone Payment From Pfizer - Quick Facts (RTTNews)
29.12.16	Bank of America, Facebook, Micron, Pfizer Inc. and Starbucks offer trade returns of over 23% (PR Newswire)
25.12.16	The Year That Was: Novel Drug Approvals Of 2016 (RTTNews)
23.12.16	Investors: Target a 21% return on Facebook, or get option-trade ideas on General Electric, Pfizer Inc., Walmart Stores Inc. and Weight Watchers or any stock you choose (PR Newswire)
21.12.16	Pfizer: FDA To Review SNDA For IBRANCE Inhibitor - Quick Facts (RTTNews)
21.12.16	BioInvent Announces Cancer Immunotherapy Research Collaboration and License Agreement With Pfizer and Issues New Shares to Pfizer (PR Newswire)
21.12.16	BioInvent Announces Cancer Immunotherapy Research Collaboration and License Agreement With Pfizer and Issues New Shares to Pfizer (PR Newswire)
19.12.16	Pfizer Gets EU Nod For Nimenrix To Treat Invasive Meningococcal Disease (RTTNews)
16.12.16	Research Reports on Drug Makers Equities -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
15.12.16	Bank of America, Ford, General Electric, Pfizer Inc., and Wells Fargo & Co. and more offer option-trading opportunities that offer returns of more than 20% (PR Newswire)
15.12.16	FDA Approves Pfizer's Eucrisa For Eczema (RTTNews)
12.12.16	Pfizer To Collaborate On IGNITE's Research Program On Novel Vaccinia Viruses (RTTNews)
07.12.16	Pfizer Fined In UK For Charging Unfair Prices For Anti-epilepsy Drug (RTTNews)
06.12.16	Bloomberg : Sanofi To Explore Counterbid For Actelion Amid J&J Talks (RTTNews)
05.12.16	Pfizer Reports Positive Top-Line Results For Phase 3 BFORE Study Of BOSULIF (RTTNews)
02.12.16	ARDM Out Of Orbit, CLSN To Report Data In Q1, MRK Seeks New Use For Old Drug (RTTNews)
01.12.16	IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery (PR Newswire)
01.12.16	Biotech Sector Growth Expected Upon Diminishing Concerns Over Drug Pricing (PR Newswire)
01.12.16	Pfizer Reports Positive Results From LYRICA Study In Pediatric Epilepsy Patients (RTTNews)
01.12.16	It's All Green For BLUE, HTBX Plunges On Failed Study, Watch Out For BPMC (RTTNews)
30.11.16	Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software (PR Newswire)
30.11.16	Pfizer: PF-05280014 Versus Herceptin Study Meets Primary Endpoint (RTTNews)
30.11.16	Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq (RTTNews)
30.11.16	Arrowhead Blunted, CERC Depressed, It's All Clear For NOVN, CPHR Leaves Nasdaq (RTTNews)
29.11.16	Pfizer : FDA Accepts BLA For Avelumab For Treatment Of MMCC For Priority Review (RTTNews)
29.11.16	FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review (PR Newswire)
29.11.16	FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

22:34		Dow Jones aktuell: Dow Jones zum Handelsende in Grün
20:04		Börse New York: Dow Jones wenig verändert
18:01		Verluste in New York: Dow Jones legt den Rückwärtsgang ein
17:58		FTSE 100 aktuell: FTSE 100 fällt zum Handelsende
17:58		Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter
17:58		Gewinne in Frankfurt: TecDAX zum Handelsende im Aufwind
17:58		Schwacher Handel: SPI sackt schlussendlich ab

22:34

Dow Jones aktuell: Dow Jones zum Handelsende in Grün

20:04

Börse New York: Dow Jones wenig verändert

18:01

Verluste in New York: Dow Jones legt den Rückwärtsgang ein

17:58

FTSE 100 aktuell: FTSE 100 fällt zum Handelsende

17:58

Schwache Performance in Europa: Euro STOXX 50 schlussendlich leichter

17:58

Gewinne in Frankfurt: TecDAX zum Handelsende im Aufwind